Neoplasms Metastasis Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03785925A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial CancerTreatment